Regional Players

The regional players in the BioPharma Cluster South Germany include companies, universities and other research-related institutions as well as municipal partners and financial partners.

Their partnerships with each other are a clear success factor for the region, consistently developing new technologies and services as well as acquiring skilled personnel.

Boehringer Ingelheim Pharma GmbH & Co. KG

is one of the world’s top 20 research-intensive pharmaceutical companies for biopharmaceuticals, human pharmaceuticals and animal health.

As a pioneer in biopharmaceuticals with over 35 years of experience, Biberach is Boehringer Ingelheim’s largest site worldwide for developing, manufacturing and distributing biopharmaceuticals.

Rentschler Biopharma

is a leading global Contract Development and Manufacturing Organisation (CDMO) for high-performance biopharmaceuticals. Rentschler Biopharma makes an important contribution to the care of critically ill patients.

Focusing exclusively on customer projects, Rentschler Biopharma offers bioprocess development and biopharmaceutical production as well as consulting, project planning and regulatory services. Many years of experience and their excellent solution competence ensure high quality standards for customers.

Sartorius Stedim Cellca GmbH

Sartorius Stedim Cellca GmbH  develops and produces cell lines and upstream processes for large-scale protein production of biopharmaceuticals based on mammalian cell cultures. Since 2015, the company has been part of the biopharma supplier Sartorius Stedim Biotech. The brand-new laboratory and office facility at Science Park III Ulm, which was completed at the end of 2019, nearly doubles the  company's space to 6,000 square meters. The new site offers an excellent environment to promote the growing business and leaves room for additional highly qualified staff.





Teva Biotech

develops and produces recombinant proteins and monoclonal antibodies from cell cultures, supplying the global market.

The pharmaceutical company Teva is the global leader in generics with a strong innovative medicine business. Teva has been producing biotechnological medicines since 2004 in Ulm. The company is currently investing 500 million euros in a second state-of-the-art biotech facility in Ulm in order to produce monoclonal antibodies for a variety of diseases in the future.

Vetter Pharma International GmbH

is an international specialist focusing on manufacturing sterile filling and packaging of injection systems with international customers of the pharmaceutical and biotech industries.

Vetter is a Contract Development and Manufacturing Organisation (CDMO) with headquarters in the German city of Ravensburg and production facilities in Germany, Austria and the US. Currently, a total of 5,800 people are employed in various fields, from process development and aseptic filling to packaging solutions for vials, syringes and cartridges.

Ulm Chamber of Commerce and Industry

The Ulm Chamber of Commerce and Industry represents the interests of all member companies in the region, committing to improving their entrepreneurial conditions. The Ulm CCI has taken on an important intermediary role between companies, science and the municipal partners of the BioPharmaCluster South Germany.

Biberach University of Applied Sciences

Biberach University of Applied Sciences (BUAS) makes an indispensable contribution to the future of the science location Biberach by applying transfer-oriented research and application-based training opportunities of professionals, including in the field of pharmaceutical and industrial biotechnology.

Biotechnology is a thematic focus of Biberach University of Applied Sciences when it comes to studying, training, research and transfer. As a University of Applied Sciences, BUAS offers application-related Bachelor's and Master's degree programmes, accompanied by progressive research and transfer projects with respective doctoral opportunities.

Ulm University

Ulm University is a research-focused university and with more than 10,000 students signed up for classes in the fields of medicine, science and technology, the university has become the scientific city’s innovation centre.

ecoSPECS GmbH is a leading provider of engineering services for quality systems with internationally renowned clients in the fields of life science, hospitals and medical technology.

Boehringer Ingelheim Therapeutics GmbH (previous Labor Dr. Merk und Kollegen GmbH) is a centre of excellence for virology and offers process development and GMP-manufacturing of viral gene therapeutics and oncolytic viral therapeutics as well as vaccines including analytical characterization.

Reinraumtechnik Ulm is a developer of innovative cleanroom solutions with a special focus on the domestic and foreign pharmaceutical industry.

Südpack Medica AG offers solution-oriented services for sterile medical packaging with state-of-the-art safety standards.